Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Related Citations for PubMed (Select 1190737)

1.

Phenylketonuria as a balanced polymorphism: the nature of the heterozygote advantage.

Woolf LI, McBean MS, Woolf FM, Cahalane SF.

Ann Hum Genet. 1975 May;38(4):461-9.

PMID:
1190737
2.

Increased "reproductive casualty" in heterozygotes for phenylketonuria.

Saugstad LF.

Clin Genet. 1973;4(2):105-14. No abstract available.

PMID:
4730939
3.

The high frequency of phenylketonuria in Ireland and Western Scotland.

Woolf LI.

J Inherit Metab Dis. 1978;1(3):101-3. No abstract available.

PMID:
116076
5.

Plasma amino acid pattern in phenylketonuric heterozygotes during pregnancy.

Cabalska B, Nowaczewska I, Duczyńska N.

Biochem Med. 1982 Jun;27(3):269-77. No abstract available.

PMID:
7115361
6.

Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.

Karateke A, Haliloglu B, Gurbuz A.

J Matern Fetal Neonatal Med. 2005 Nov;18(5):299-304.

PMID:
16390788
7.

[Effect of maternal genetic heterozygosity].

Bliumina MG, Vtorova VG, Grinio LP, Uberiia EI, Ovchinnikova VM.

Genetika. 1975;11(8):147-53. Russian.

PMID:
1240817
8.

Heterozygote advantage for the phenylketonuria allele.

Saugstad LF.

J Med Genet. 1977 Feb;14(1):20-4.

9.

A polymorphism in the MTHFD1 gene increases a mother's risk of having an unexplained second trimester pregnancy loss.

Parle-McDermott A, Pangilinan F, Mills JL, Signore CC, Molloy AM, Cotter A, Conley M, Cox C, Kirke PN, Scott JM, Brody LC.

Mol Hum Reprod. 2005 Jul;11(7):477-80.

10.

Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria.

Lidsky AS, Ledley FD, DiLella AG, Kwok SC, Daiger SP, Robson KJ, Woo SL.

Am J Hum Genet. 1985 Jul;37(4):619-34.

11.

Phenylketonuria: variable phenotypic outcomes of the R261Q mutation and maternal PKU in the offspring of a healthy homozygote.

Kleiman S, Vanagaite L, Bernstein J, Schwartz G, Brand N, Elitzur A, Woo SL, Shiloh Y.

J Med Genet. 1993 Apr;30(4):284-8.

12.

Association of PLA2 polymorphism of the ITGB3 gene with early fetal loss.

Ruzzi L, Ciarafoni I, Silvestri L, Semeraro ML, Abeni D.

Fertil Steril. 2005 Feb;83(2):511-2.

PMID:
15705408
13.

[Prenatal screening for phenylketonuria in 2 families by trophoblast biopsy].

Rey F, Berthelon M, Munnich A, Frézal J, Rey J.

Arch Fr Pediatr. 1987 Oct;44(8):565-8. French.

PMID:
2894821
14.

Anthropological significance of phenylketonuria and the importance of heterozygote advantage.

Saugstad LF.

Ir Med J. 1976 Sep 30;69(15):405-10. No abstract available.

PMID:
1010731
15.

The Maternal Phenylketonuria Collaborative Study: a status report.

[No authors listed]

Nutr Rev. 1994 Nov;52(11):390-3. No abstract available.

PMID:
7854653
16.
17.

Increased risk for fetal loss in carriers of the factor V Leiden mutation.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Ann Intern Med. 1999 May 4;130(9):736-9.

PMID:
10357692
18.

A study of the cause of the high incidence of phenylketonuria in Ireland and west Scotland.

Woolf LI.

Ir Med J. 1976 Sep 30;69(15):398-401. No abstract available.

PMID:
1010729
19.

RFLPs of the phenylalanine hydroxylase gene in the Italian population.

Dianzani I, Farinasso L, Fortina P, Camaschella C, Ponzone R, Dahl HH, Cotton RG, Ponzone A.

J Inherit Metab Dis. 1989;12(2):162-5.

PMID:
2569049
20.

[Spontaneous abortions in women-carriers of the phenylketonuria gene].

Bliumina MG.

Akush Ginekol (Mosk). 1972 May;48(5):52-5. Russian. No abstract available.

PMID:
5071127
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk